New behavioral program aims to ease Aging-Related struggles in lung cancer patients
NCT ID NCT06636721
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to create a brief behavioral intervention for older adults (60+) with lung cancer, addressing aging-specific concerns like depression, anxiety, pain, and shortness of breath. In the first phase, patients, caregivers, and providers give feedback on the program. In the second phase, 16 patients test the revised program to see if it is feasible and acceptable. The goal is to help patients manage symptoms and engage with healthcare services better.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- LuCA Behavioral Intervention (cognitive behavioral therapy and acceptance and commitment therapy techniques)
- What this could lead to
- If successful, this could provide a practical, non-drug program to help older adults with lung cancer better cope with symptoms and improve their quality of life.
- What could go wrong
- This is a very early, small study (46 participants) focused on developing and testing feasibility, not proving effectiveness. The intervention may not work for everyone or may need further refinement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duke University Health System
RECRUITINGDurham, North Carolina, 27705, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Your Tumor's DNA might predict immunotherapy success
- Can a new PET tracer light up hidden cancers?
- Fellow veterans may hold the key to earlier lung cancer detection